20
Participants
Start Date
May 31, 2015
Primary Completion Date
August 31, 2015
Study Completion Date
September 30, 2015
Lorcaserin
10 mg 2 times per day from Day 3 to 9 and one time on Day 10
Placebo
10 mg 2 times per day from Day 3 to 9 and one time on Day 10
Cocaine Infusion
Screening / Session 1, Study Day -2: 20 mg cocaine, followed by a saline infusion, followed by 40 mg cocaine Baseline/ Session 2, Study Day 1: Saline or 20 mg cocaine followed by either 20 mg cocaine or saline Baseline / Session 3, Study Day 2: Saline or 40 mg cocaine followed by either 40 mg cocaine or saline Treatment / Session 4, Study Day 9: Saline or 20 mg cocaine followed by either 20 mg cocaine or saline Treatment / Session 5, Study Day10: Saline or 40 mg cocaine followed by either 40 mg cocaine or saline
Vince Associates Clinical Research, Inc., Overland Park
National Institute on Drug Abuse (NIDA)
NIH